查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1605912

非侵入性产前检查市场，规模，占有率，趋势，产业分析报告:各妊娠期间，各零件，各方法，各用途，各最终用途，各地区 - 市场预测 2025年～2034年

Non-Invasive Prenatal Testing Market Size, Share, Trends, Industry Analysis Report: By Gestation Period, Component, Method, Application, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2034 年，非侵入性产前检测 (NIPT) 市场规模预计将达到 113.9 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

非侵入性产前检测 (NIPT) 是指使用孕妇的血液样本筛检胎儿某些遗传性疾病（例如唐氏症）的方法。此测试分析母亲血液中循环的胎儿 DNA 小片段。它受到用户的青睐，因为与侵入性方法相比，它准确且安全。

遗传疾病早期检测的重要性日益增加，这是 NIPT 市场的主要推动因素。基因组技术和生物资讯学的重大进步正在推动 NIPT 市场的发展。新一代定序 (NGS) 技术的改进提高了胎儿 DNA 分析的准确性和效率。这些创新带来了更实惠、更容易获得的 NIPT 选择，从而提高了医疗保健提供者和患者对 NIPT 的采用率。例如，2021 年 5 月，Illumina, Inc. 和 Next Generation Genomic Co., Ltd. 宣布推出 VeriSeq NIPT Solution v2，这是一种基于 CE-IVD、NGS 的 NIPT 方法。随着技术的不断发展，我们期望看到 NIPT 的功能和定价进一步改进。

非侵入性产前检测市场是由价格竞争和透过策略合作伙伴关係进行技术创新等策略的激烈竞争所推动的。例如，2021年7月，加州Pacific Biosciences, Inc.宣布收购Omniome。此次收购使 Pacific Biosciences 能够以有利于客户的创意方式扩大其定序仪市场机会。 Omniome 凭藉其创新方法，旨在提供高度准确的短链定序平台，以进入快速扩展的临床应用领域，例如非侵入性产前检测和肿瘤学。

此外，2024 年 10 月，Yourgene Health 在 Genetix 上安装了哥伦比亚首个非侵入性产前检测 (NIPT) 工作流程。该服务为哥伦比亚的孕妇提供快速、准确的 NIPT 结果，减少週转时间和运输问题。

非侵入性产前检测 (NIPT) 市场报告亮点

透过方法分析，母体血浆游离 DNA 检测在 2024 年占据市场主导地位，这主要是因为与传统的侵入性方法相比，其风险最小且准确性更高。

从应用来看，由于NIPT 在检测21 三体（唐氏症）、18 三体症（爱德华兹症候群）和13 三体（帕陶症候群）等常见染色体异常方面的作用，三体细分市场将在2024 年成为市场。

由于先进的医疗基础设施、较高的认知度以及先进技术的稳定实施，北美在 2024 年占据了市场主导地位。

由于经济成长、技术创新、地理扩张和战略合作伙伴关係，亚太地区预计将实现最快的复合年增长率。

主要市场参与者包括Agilent Technologies, Inc.，Centogene N.V.，Eurofins LifeCodexx GmbH，F． Hoffmann-La Roche Ltd.(Ariosa Diagnostics)，Agilent Technologies, Inc.(Ariosa Diagnostics)，Illumina, Inc.，Laboratory Corp. of America Holdings，MedGenome Labs Ltd.，Myriad Women's Health, Inc.，Natera, Inc.，Progenity, Inc.，Qiagen，Quest Diagnostics, Inc.，Thermo Fisher Scientific, Inc.

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球非侵入性产前检查(NIPT)市场洞察

  • 用途概述
  • 非侵入性产前检查(NIPT)市场动态
    • 促进因素和机会
      • 定序技术和生物资讯学的技术不断进步
      • 生育年龄增加
    • 抑制因素和挑战
      • 有些国家禁止将 NIPT 用于基于非医学背景的性别选择。
  • PESTEL分析
  • 非侵入性产前检查(NIPT)市场用途趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球非侵入性产前检查(NIPT)市场:各妊娠期间

  • 主要调查结果
  • 简介
  • 0～12週
  • 13～24週
  • 25～36週

第6章 全球非侵入性产前检查(NIPT)市场:各零件

  • 主要调查结果
  • 简介
  • 消耗品
  • 设备
  • 软体
  • 服务

第7章 全球非侵入性产前检查(NIPT)市场:各方法

  • 主要调查结果
  • 简介
  • 母体血浆检验的脱离DNA
  • 超音波检测
  • 生物化学筛检检验
  • 其他

第8章 全球非侵入性产前检查(NIPT)市场:各用途

  • 主要调查结果
  • 简介
  • 单体性
  • 三体性
  • 微缺失症候群
  • 其他

第9章 全球非侵入性产前检查(NIPT)市场:各最终用途

  • 主要调查结果
  • 简介
  • 诊断中心
  • 医院和诊疗所

第10章 全球非侵入性产前检查(NIPT)市场:各地区

  • 主要调查结果
  • 简介
    • 非侵入性产前检查(NIPT)市场评估:地区，2020年～2034年
  • 北美
    • 北美:各妊娠期间，2020～2034年
    • 北美:各零件，2020～2034年
    • 北美:各方法，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各妊娠期间，2020～2034年
    • 欧洲:各零件，2020～2034年
    • 欧洲:各方法，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各妊娠期间，2020～2034年
    • 亚太地区:各零件，2020～2034年
    • 亚太地区:各方法，2020～2034年
    • 亚太地区:各用途，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各妊娠期间，2020～2034年
    • 中东·非洲:各零件，2020～2034年
    • 中东·非洲:各方法，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各妊娠期间，2020～2034年
    • 南美:各零件，2020～2034年
    • 南美:各方法，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各最终用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • Agilent Technologies, Inc.
  • Centogene N.V
  • Eurofins LifeCodexx GmbH
  • F;Hoffmann-La Roche Ltd
  • Illumina, Inc
  • Laboratory Corp. of America Holdings
  • MedGenome Labs Ltd
  • Myriad Women's Health, Inc.
  • Natera, Inc.
  • Progenity, Inc.
  • Qiagen
  • Quest Diagnostics, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: PM1836

The non-invasive prenatal testing market size is expected to reach USD 11.39 billion by 2034, according to a new study by Polaris Market Research. The report "Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Trends, Industry Analysis Report: By Gestation Period (0-12 Weeks, 13-24 Weeks, and 25-36 Weeks), Component, Method, Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Non-invasive prenatal testing (NIPT) refers to a method used to screen for certain genetic conditions in a fetus, such as Down syndrome, using a blood sample from the pregnant individual. This test analyzes small fragments of fetal DNA that are circulating in the maternal blood. It is a preferred option among users for its accuracy and safety compared to invasive methods.

The growing importance of early detection of genetic disorders is a primary driver for the NIPT market. Significant advancements in genomic technology and bioinformatics have propelled the NIPT market. Improvements in next-generation sequencing (NGS) technology have enhanced the accuracy and efficiency of fetal DNA analysis. These technological innovations have led to more affordable and accessible NIPT options, thereby expanding its adoption among healthcare providers and patients. For instance, in May 2021, Illumina, Inc. and Next Generation Genomic Co., Ltd. announced the launch of VeriSeq NIPT Solution v2, a CE-IVD, NGS-based approach to NIPT. As technology continues to evolve, it is expected to improve the capabilities and affordability of NIPT further.

The non-invasive prenatal testing market is driven by intense competition with strategies including price competitiveness and technological innovation with strategic partnerships. For instance, in July 2021, Pacific Biosciences of California, Inc. announced the acquisition of Omniome. With the acquisition, Pacific Biosciences will be able to expand the market opportunity for sequencing in creative ways that benefit customers. Through its innovative methodology, Omniome aims to provide an accurate short-read sequencing platform to enable it to enter rapidly expanding clinical application areas such as non-invasive prenatal testing and oncology.

Additionaly, in October 2024, Yourgene Health installed the first non-invasive prenatal testing (NIPT) workflow in Colombia at Genetix. The service will deliver fast, precise NIPT results for expectant parents in Colombia, serving to reduce turnaround times and delivery problems.

Non-Invasive Prenatal Testing (NIPT) Market Report Highlights

By method analysis, the cell-free DNA in maternal plasma tests segment dominated the market in 2024, mainly attributed to its minimal risk and superior accuracy compared to traditional invasive methods.

By application analysis, the trisomy segment dominated the market in 2024 owing to NIPT's role in detecting common chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome).

North America dominated the market in 2024 due to advanced healthcare infrastructure, high awareness levels, and robust adoption of advanced technologies.

Asia Pacific is expected to register the fastest CAGR, owing to economic growth, technological innovation, geographic expansion, and strategic partnerships.

The key market players include Agilent Technologies, Inc.; Centogene N.V.; Eurofins LifeCodexx GmbH; F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics); Illumina, Inc.; Laboratory Corp. of America Holdings; MedGenome Labs Ltd.; Myriad Women's Health, Inc.; Natera, Inc.; Progenity, Inc.; Qiagen; Quest Diagnostics, Inc.; and Thermo Fisher Scientific, Inc.

Polaris Market Research has segmented the non-invasive prenatal testing market report based on gestation period, component, method, application, end use, and region:

By Gestation Period Outlook (Revenue - USD Billion, 2020-2034)

  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks

By Component Outlook (Revenue - USD Billion, 2020-2034)

  • Consumables
  • Instruments
  • Software
  • Services

By Method Outlook (Revenue - USD Billion, 2020-2034)

  • Cell-Free DNA in Maternal Plasma Tests
  • Ultrasound Detection
  • Biochemical Screening Tests
  • Others

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Monosomy
  • Trisomy
  • Microdeletion Syndrome
  • Others

By End-Use Outlook (Revenue - USD Billion, 2020-2034)

  • Diagnostic Centers
  • Hospitals and Clinics
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Non-Invasive Prenatal Testing (NIPT) Market Insights

  • 4.1. Non-Invasive Prenatal Testing (NIPT) Market - Application Snapshot
  • 4.2. Non-Invasive Prenatal Testing (NIPT) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising technological advancements in sequencing technologies and bioinformatics
      • 4.2.1.2. Rise in Maternal Age
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Application of NIPT for sex selection on non-medical backgrounds is prohibited in some countries.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Non-Invasive Prenatal Testing (NIPT) Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • 5.3. 0-12 weeks
    • 5.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 0-12 weeks, by Region, 2020-2034 (USD Billion)
  • 5.4. 13-24 weeks
    • 5.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 13-24 weeks, by Region, 2020-2034 (USD Billion)
  • 5.5. 25-36 weeks
    • 5.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 25-36 weeks, by Region, 2020-2034 (USD Billion)

6. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • 6.3. Consumables
    • 6.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Consumables, by Region, 2020-2034 (USD Billion)
  • 6.4. Instruments
    • 6.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 6.5. Software
    • 6.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Software, by Region, 2020-2034 (USD Billion)
  • 6.6. Services
    • 6.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Services, by Region, 2020-2034 (USD Billion)

7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • 7.3. Cell-Free DNA in Maternal Plasma Tests
    • 7.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Cell-Free DNA in Maternal Plasma Tests, by Region, 2020-2034 (USD Billion)
  • 7.4. Ultrasound Detection
    • 7.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Ultrasound Detection, by Region, 2020-2034 (USD Billion)
  • 7.5. Biochemical Screening Tests
    • 7.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Biochemical Screening Tests, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Monosomy
    • 8.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Monosomy, by Region, 2020-2034 (USD Billion)
  • 8.4. Trisomy
    • 8.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Trisomy, by Region, 2020-2034 (USD Billion)
  • 8.5. Microdeletion Syndrome
    • 8.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Microdeletion Syndrome, by Region, 2020-2034 (USD Billion)
  • 8.6. Other
    • 8.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 9.3. Diagnostic Centers
    • 9.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 9.4. Hospitals and Clinics
    • 9.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)

10. Global Non-Invasive Prenatal Testing (NIPT) Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Non-Invasive Prenatal Testing (NIPT) Market - North America
    • 10.3.1. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.3.2. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.3.3. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.3.4. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.3.5. North America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.3.7. Non-Invasive Prenatal Testing (NIPT) Market - U.S.
      • 10.3.7.1. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.3.7.2. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.3.7.3. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.3.7.4. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.5. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.3.8. Non-Invasive Prenatal Testing (NIPT) Market - Canada
      • 10.3.8.1. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.4. Non-Invasive Prenatal Testing (NIPT) Market - Europe
    • 10.4.1. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.6. Non-Invasive Prenatal Testing (NIPT) Market - UK
      • 10.4.6.1. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.7. Non-Invasive Prenatal Testing (NIPT) Market - France
      • 10.4.7.1. France: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.8. Non-Invasive Prenatal Testing (NIPT) Market - Germany
      • 10.4.8.1. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.9. Non-Invasive Prenatal Testing (NIPT) Market - Italy
      • 10.4.9.1. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.10. Non-Invasive Prenatal Testing (NIPT) Market - Spain
      • 10.4.10.1. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.11. Non-Invasive Prenatal Testing (NIPT) Market - Netherlands
      • 10.4.11.1. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.12. Non-Invasive Prenatal Testing (NIPT) Market - Russia
      • 10.4.12.1. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.5. Non-Invasive Prenatal Testing (NIPT) Market - Asia Pacific
    • 10.5.1. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.6. Non-Invasive Prenatal Testing (NIPT) Market - China
      • 10.5.6.1. China: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.7. Non-Invasive Prenatal Testing (NIPT) Market - India
      • 10.5.7.1. India: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.8. Non-Invasive Prenatal Testing (NIPT) Market - Malaysia
      • 10.5.8.1. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.9. Non-Invasive Prenatal Testing (NIPT) Market - Japan
      • 10.5.9.1. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.10. Non-Invasive Prenatal Testing (NIPT) Market - Indonesia
      • 10.5.10.1. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.11. Non-Invasive Prenatal Testing (NIPT) Market - South Korea
      • 10.5.11.1. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.12. Non-Invasive Prenatal Testing (NIPT) Market - Australia
      • 10.5.12.1. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.6. Non-Invasive Prenatal Testing (NIPT) Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.6. Non-Invasive Prenatal Testing (NIPT) Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.7. Non-Invasive Prenatal Testing (NIPT) Market - UAE
      • 10.6.7.1. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.8. Non-Invasive Prenatal Testing (NIPT) Market - Israel
      • 10.6.8.1. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.9. Non-Invasive Prenatal Testing (NIPT) Market - South Africa
      • 10.6.9.1. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.10. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • 10.7. Non-Invasive Prenatal Testing (NIPT) Market - Latin America
    • 10.7.1. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.6. Non-Invasive Prenatal Testing (NIPT) Market - Mexico
      • 10.7.6.1. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.7. Non-Invasive Prenatal Testing (NIPT) Market - Brazil
      • 10.7.7.1. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.8. Non-Invasive Prenatal Testing (NIPT) Market - Argentina
      • 10.7.8.1. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.9. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Agilent Technologies, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Centogene N.V
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eurofins LifeCodexx GmbH
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. F; Hoffmann-La Roche Ltd
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Illumina, Inc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Laboratory Corp. of America Holdings
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. MedGenome Labs Ltd
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Myriad Women's Health, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Natera, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Progenity, Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Qiagen
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Quest Diagnostics, Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Thermo Fisher Scientific, Inc.
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development

List of Tables:

  • Table 1 Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 2 Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 3 Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 4 Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 5 Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 6 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 7 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 8 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 9 North America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 10 North America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 12 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 13 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 14 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 15 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 17 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 18 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 19 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Canada: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 22 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 23 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 24 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 26 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 27 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 28 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 29 UK: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 30 UK: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 France: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 32 France: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 33 France: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 34 France: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 35 France: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 36 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 37 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 38 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 39 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Germany: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 42 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 43 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 44 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Italy: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 47 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 48 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 49 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 50 Spain: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 56 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 57 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 58 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 59 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 60 Russia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 71 China: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 72 China: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 73 China: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 74 China: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 75 China: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 India: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 77 India: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 78 India: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 79 India: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 80 India: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 86 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 87 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 88 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 89 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Japan: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 96 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 97 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 98 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 99 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 100 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 102 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 103 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 104 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 105 Australia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 122 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 123 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 124 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 125 UAE: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 126 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 127 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 128 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 129 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 130 Israel: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 131 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 132 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 133 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 134 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 135 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 141 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 142 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 143 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 144 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 145 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 146 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 147 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 148 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 149 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 150 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 151 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 152 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 153 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 154 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 155 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 156 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 157 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 158 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 159 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 160 Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global Non-Invasive Prenatal Testing (NIPT) Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Gestation Period
  • Figure 7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Component
  • Figure 9. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Method
  • Figure 11. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 14. Market by End Use
  • Figure 15. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2024 & 2034 (USD Billion)